UT Southwestern Medical Center
Dallas, Texas, 75390, United States
NCT Number: NCT02525783
The purpose of this study is to demonstrate safety and effectiveness of the Aequalis Pyrocarbon Humeral Head in hemiarthroplasty at 24 months.
Looking for future studies?
Notify Me22 year and older
All sexes
Interventional
Dallas, Texas, 75390, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hemi Shoulder Arthroplasty
Time frame: 24 Months
A subject is a success at 24 months if:
Time frame: 24 Months
Constant Score: In this score, 35 points are allocated for subjective assessments of pain and activities of daily living and 65 points are available for objective measures of range of movement and shoulder strength. A young healthy patient can therefore have a maximum score of 100 points. The minimum score is 0 points. The range of the score is 0-100 for both the Constant Score and the adjusted Constant score. A higher value represents a better outcome.
Average of 2 pain scores (15 points max) Sum of 4 activities of daily living questions (20 points max) Sum of 4 ROM measure (40 points max) Power score (25 points max)
Change in Constant Score and Adjusted Constant Score at 24 months compared to baseline is presented along with absolute values.
Time frame: 24 Months
American Shoulder and Elbow Surgeons Standardized Shoulder Assessment. The original ASES consists of 2 portions, a medical professional assessment section and a patient self-report section. The patient self-report section utilized in this study is a condition specific scale intended to measure functional limitations and pain of the shoulder. The assessment takes approximately 5 minutes to complete and consists of 2 dimensions: pain and activities of daily living. The pain score is calculated from the single pain question and the function score from the sum of the 10 questions addressing function. The pain score and function composite score are weighted equally (50 points each) and combined for a total score out of a possible 100 points. The minimum score is 0 and the maximum score is 100. A higher value represents a better outcome.
Change in American Shoulder and Elbow Surgeons (ASES) Score at 24 months compared to baseline are presented.
Time frame: 24 Months
The SANE rating is determined by the subject's written response to the following question "How would you rate your shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"
Change in Single Assessment Numeric Evaluation (SANE) at 24 months compared to baseline
Time frame: 24 Months
EQ-5D: a standardized instrument for use as a measure of health outcome. It is cognitively simple, takes only a few minutes to complete, and provides a simple descriptive profile as well as a single index value for health status. Scale 0 to 1; 1 (representing full health) to 0 (representing dead).
Change in EQ-5D score at 24 months compared to baseline
Time frame: 24 Months
Pain is measured by a visual analog scale (from 0-10). The subject responds to the question: How bad is your pain TODAY. 0 is no pain; 10 is pain as bad as it can be.
Change in pain measured by a visual analog scale (VAS) at 24 months compared to baseline
Time frame: 24 Months
Range of Motion (ROM) is a movement test conducted on a joint to diagnose level of pain and function. The shoulder joint has a greater Range of Motion than all other joints in the body. In this study, ROM was measured using a goniometer for forward flexion in relation to the thorax, abduction, and external rotation (arm at side and arm abducted to 90°).
Change in Range of Motion (ROM) at 24 months compared to baseline.
Time frame: 24 Months
The subject's strength will be assessed using a fixed force gauge. The fixed force gauge is held in place by the examiner and the subject pulls upward with maximum effort for approximately five seconds. The test can be completed up to three times and the maximum score is used, however all three pulls will be recorded. The test is done only on the affected arm. The result of this test contributes to the Constant score calculation.
Change in Strength testing at 24 months compared to baseline
Time frame: 24 Months
Adverse Events data will be collected and summarized at 24 months.
Time frame: 24 Months
A revision is a procedure that adjusts or in any way modifies or removes any component of the original implant configuration, with or without replacement of a component, after the initial surgery. A revision may also include adjusting the position of the original configuration. An explant is a revision that includes permanent removal of any system component. If a subject has a revision that includes an addition of a glenoid component (revision to TSA) the Pyrocarbon humeral head must be permanently explanted.
The Revision Rate will be calculated and summarized at 24 months.
Time frame: 24 Months
The level of satisfaction with the shoulder will be summarized at 24 months.
Time frame: 24 Months
The follow data will be summarized at 24 Months:
glenohumeral joint space width, glenoid osteophytes, glenoid morphology, humeral component radiolucency, osteolysis, migration, subsidence, subluxation, acromial humeral distance, anatomic fracture, and additional observations
Stryker Trauma and Extremities
Industry
Aequalis Pyrocarbon Humeral Head IDE Study
Acronym: PYC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02087436
Arthritis, Arthritis, Rheumatoid
Gyeonggi-do, South Korea
View Trial DetailsNCT00578851
Arthritis, Avascular Necrosis
Cedar Rapids, Iowa, United States
View Trial DetailsNCT00757354
Arthritis, Arthritis, Rheumatoid
Bristol, United Kingdom
View Trial DetailsNCT05630053
Arthritis, Arthritis, Rheumatoid
Westminster, Colorado, United States
View Trial Details